Ribavirin for chronic hepatitis prevention among patients with hematologic malignancies

Emerging Infectious Diseases

Volumn 21, Issue 8, 2015, Pages 1466-1469

  Tavitian, Suzanne ^a,b   Peron, Jean Marie ^a,c   Huguet, Françoise ^b   Kamar, Nassim ^c   Abravanel, Florence ^c   Beyne Rauzy, Odile ^a,b   Oberic, Lucie ^b   Faguer, Stanislas ^c   Alric, Laurent ^a,c   Roussel, Murielle ^b   Gaudin, Clément ^a,c   Ysebaert, Loïc ^b   Huynh, Anne ^b   Recher, Christian ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b Institut Universitaire du Cancer   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBAVIRIN; ANTIVIRUS AGENT;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATITIS E; HUMAN; LABORATORY TEST; MALE; MIDDLE AGED; NONHUMAN; POLYMERASE CHAIN REACTION; PRURITUS; VIRAL CLEARANCE; GENETICS; HEMATOLOGIC NEOPLASMS; HEPATITIS E VIRUS; HEPATITIS, CHRONIC; VIROLOGY;

ANTIVIRAL AGENTS; HEMATOLOGIC NEOPLASMS; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS, CHRONIC; HUMANS; RIBAVIRIN;

EID: 84937401015     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2108.150199     Document Type: Article

References (14)

1. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27:116-38. http://dx.doi.org/ 10.1128/CMR.00057-13
2. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B,et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384:1766-73. http://dx.doi.org/10.1016/S0140-6736(14)61034-5
3. Kamar N, Selves J, Mansuy J-M, Ouezzani L, Péron J-M, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811-7. http://dx.doi.org/10.1056/NEJMoa0706992
4. Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med. 2011;155:479-80. http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00017
5. Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper MEI, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood. 2013;122:1079-86. http://dx.doi.org/10.1182/blood-2013-03-492363
6. Tavitian S, Péron J-M, Huynh A, Mansuy J-M, Ysebaert L, Huguet F, et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol. 2010; 49:141-4. http://dx.doi.org/10.1016/j.jcv.2010.06.016
7. Halac U, Béland K, Lapierre P, Patey N, Ward P, Brassard J, et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr. 2012 May;160(5):871-4.e1.
8. Pfefferle S, Frickmann H, Gabriel M, Schmitz N, Günther S, Schmidt-Chanasit J. Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany. Infection. 2012;40:451-4. http://dx.doi.org/10.1007/s15010-011-0220-7
9. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, et al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol. 2008;23:1269-79. http://dx.doi.org/10.1007/s00467-008-0814-1
10. Geng Y, Zhang H, Huang W, Harrison T, Geng K, Li Z, et al. Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat Mon. 2014;14:e15618.http://dx.doi.org/10.5812/hepatmon.15618
11. Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370:1111-20. http://dx.doi.org/ 10.1056/NEJMoa1215246
12. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology. 2010;139:1612-8. http://dx.doi.org/10.1053/j.gastro.2010.08.002
13. Woolson KL, Forbes A, Vine L, Beynon L, McElhinney L, Panayi V, et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther. 2014;40:1282-91. http://dx.doi.org/10.1111/apt.12986
14. Mansuy J-M, Huynh A, Abravanel F, Recher C, Peron JM, Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis. 2009;48:373-4. http://dx.doi.org/10.1086/595893